Synergistic effect of β-amyloid protein and interferon gamma on nitric oxide production by C2C12 muscle cells

Brain

Volumn 123, Issue 2, 2000, Pages 374-379

  Baron, Pierluigi ^a   Galimberti, Daniela ^a   Meda, Lucia ^a   Prat, Elisabetta ^a   Scarpini, Elio ^a   Conti, Giancarlo ^a   Moggio, Maurizio ^a   Prelle, Alessandro ^a   Scarlato, Guglielmo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Apoptosis; IBM; Muscle cell; Nitric oxide; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; DNA FRAGMENT; GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE INDUCTION; INCLUSION BODY MYOSITIS; MOUSE; MUSCLE CELL; MUSCLE INJURY; NONHUMAN; NORTHERN BLOTTING; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033958975     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.2.374     Document Type: Article

References (34)

1. Askanas V, Engel WK. New advances in inclusion-body myositis. [Review]. Curr Opin Rheumatol 1993; 5: 732-41.
2. Askanas V, Engel WK, Alvarez RB, Glenner GG. β-amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis [letter]. Lancet 1992a; 339: 560-1.
3. Askanas V, Engel WK, Alvarez RB. Light and electron microscopic localization of β-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol 1992b; 141: 31-6.
4. Askanas V, McFerrin J, Baque S, Alvarez RB, Sarkozi E, Engel WK. Transfer of β-amyloid precursor protein gene using adenovirus vector causes mitochondrial abormalities in cultured normal human muscle. Proc Natl Acad Sci USA 1996; 93: 1314-9.
5. Askanas V, McFerrin J, Alvarez RB, Baqué S, Engel WK. β-APP gene transfer into cultured human muscle induces inclusion-body myositis aspects. Neuroreport 1997; 8: 2155-8.
6. Balon TW, Nadler JL. Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol 1994; 77: 2519-21.
7. Blough NV, Zafiriou OC. Reaction of superoxide with nitric oxide to form peroxynitrite in alkaline aqueous solution. Inorg Chem 1985; 24: 3504-5.
8. Brown RH. Free radicals, programmed cell death and muscular dystrophy [editorial]. [Review]. Curr Opin Neurol 1995; 8: 373-8.
9. Dawson TM, Dawson V. Nitric oxide: actions and pathological roles. Neuroscientist 1994; 1: 9-20.
10. Dawson TM, Snyder SH. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. [Review]. J Neurosci 1994; 14: 5147-9.
11. Figarella-Branger D, Baeta-Machado A, Putzu G, Pellissier JF. Inclusion body myositis: pathologic changes. In Askanas V, Serratrice G, Engel WK, editors. Inclusion-body myositis and myopathies. Cambridge: Cambridge University Press; 1998. p. 137-55.
12. Forstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, et al. Nitric oxide synthase isoenzymes: characterization, purification, molecular cloning, and functions. [Review]. Hypertension 1994; 23: 1121-31.
13. Gambetti P, Perry G. Alzheimer's disease and prion proteins: a meeting made in muscle. [Review]. Am J Pathol 1994; 145: 1261-4.
14. Good PF, Werner P, Hsu A, Olanow CW, Perl DP. Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol 1996; 149: 21-8.
15. Goodwin JL, Uemura E, Cunnick JE. Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ. Brain Res 1995; 692: 207-14.
16. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bc1-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6.
17. Karpati G, Carpenter S. Pathology of the inflammatory myopathies. In: Mastaglia FL, editor. Inflammatory myopathies. Bailliere's clinical neurology. Vol. 2(3). London: Bailliere Tindall; 1993. p. 527-56.
18. Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle [letter]. Nature 1994; 372: 546-8.
19. Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 1992; 267: 6370-4.
20. Maury CP. Molecular pathogenesis of β-amyloidosis in Alzheimer's disease and other cerebral amyloidosis. [Review]. Lab Invest 1995; 72: 4-16.
21. Meda L, Bonaiuto C, Baron P, Otvos L Jr, Rossi F, Cassatella MA. Priming of monocyte respiratory burst by β-amyloid fragment (25-35). Neurosci Lett 1996; 219: 91-4.
22. Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, et al. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 1995; 374: 647-50.
23. Mendell JR, Sahenk Z, Gales T, Paul L. Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. Arch Neurol 1991; 48: 1229-34.
24. Mikol J, Engel AG. Inclusion body myositis. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill; 1994. p. 1384-98.
25. Moggio M, Jann S, Adobbati L, Prelle A, Gallanti A, Fagiolari G, et al. Ultrastructural localization of calcium binding sites on human muscle cell surface. Muscle Nerve 1989; 12: 910-4.
26. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. [Review]. J Biol Chem 1994; 269: 13725-8.
27. Rockett KA, Awburn MM, Aggarwal BB, Cowden WB, Clark IA. In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria. Infect Immun 1992; 60: 3725-30.
28. Sarkozi E, Askanas V, Johnson SA, McFerrin J, Engel WK. Expression of β-amyloid precursor protein gene is developmentally regulated in human muscle fibers in vivo and in vitro. Exp Neurol 1994; 128: 27-33.
29. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997; 17: 2653-7.
30. Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 1991; 88: 7773-7.
31. Williams G, Brown T, Becker L, Prager M, Giroir BP. Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes. Am J Physiol 1994; 267: R1020-5.
32. Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977; 270: 725-7.
33. Yang CC, Alvarez RB, Engel WK, Askanas V. Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis. Neuroreport 1996; 8: 153-8.
34. Yang CC, Alvarez RB, Engel WK, Heller SL, Askanas V. Nitric oxide-induced oxidative stress in autosomal recessive and dominant inclusion-body myopathies. Brain 1998; 121: 1089-97.